Insider Transactions in Q1 2025 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2025
|
Jeffrey S. Heier Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,061
-1.14%
|
$18,366
$6.87 P/Share
|
|
Feb 24
2025
|
Pravin Dugel Director |
SELL
Open market or private sale
|
Direct |
21,475
-0.61%
|
$128,850
$6.87 P/Share
|
|
Feb 24
2025
|
Sanjay Nayak Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,895
-0.66%
|
$11,370
$6.84 P/Share
|
|
Feb 24
2025
|
Peter Kaiser Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,009
-1.41%
|
$18,054
$6.87 P/Share
|
|
Feb 11
2025
|
Sanjay Nayak Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
111,000
+28.0%
|
-
|
|
Feb 11
2025
|
Donald Notman Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,000
+27.16%
|
-
|
|
Feb 11
2025
|
Nadia Waheed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,000
+26.36%
|
-
|
|
Feb 11
2025
|
Pravin Dugel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750,000
+33.86%
|
-
|
|
Feb 04
2025
|
Donald Notman Officer |
SELL
Open market or private sale
|
Direct |
11,119
-5.44%
|
$77,833
$7.81 P/Share
|
|
Jan 31
2025
|
Donald Notman Officer |
SELL
Open market or private sale
|
Direct |
6,301
-2.99%
|
$44,107
$7.84 P/Share
|